To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.

Bill 118 hr 10305, also known as the "Exemption of Certain Drugs from Medicare Part D Manufacturer Discount Program Act," aims to make changes to title XVIII of the Social Security Act. Specifically, this bill seeks to exempt certain drugs from the part D manufacturer discount program under the Medicare program.

The part D manufacturer discount program was established to help lower the cost of prescription drugs for Medicare beneficiaries. However, some drugs may not benefit from this program due to various reasons such as their unique characteristics or limited availability.

If passed, this bill would provide an exemption for these specific drugs, allowing them to be excluded from the manufacturer discount program. This exemption could potentially impact the pricing and availability of these drugs for Medicare beneficiaries. Overall, the goal of Bill 118 hr 10305 is to address the specific needs of certain drugs within the Medicare program and ensure that they are not negatively impacted by the manufacturer discount program.